Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 489.04 K448.91 K819.22 K1.9 M1.1 M771.07 K 4.59 M Research & development —————— — Operating income -489.04 K-448.91 K-819.22 K-1.9 M-1.1 M-771.07 K -4.59 M Non-Operating Income, Total 3 M3.92 M4.01 M3.7 M3.34 M3.37 M 14.42 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 1.49 M1.95 M2 M1.85 M1.67 M1.68 M 7.2 M Unusual income/expense 1.51 M1.97 M2.01 M1.86 M1.67 M1.69 M 7.23 M Pretax income 2.51 M3.47 M3.19 M1.8 M2.24 M2.6 M 9.84 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 1.02 M1.52 M1.19 M-42.9 K575.61 K915.12 K 2.64 M Discontinued operations —————— — Net income 1.02 M1.52 M1.19 M-42.9 K575.61 K915.12 K 2.64 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 1.02 M1.52 M1.37 M-222.47 K575.61 K915.12 K 2.64 M Basic earnings per share (Basic EPS) 0.150.180.12-00.060.12 0.3 Diluted earnings per share (Diluted EPS) 0.150.180.12-00.060.12 0.3 Average basic shares outstanding 21.31 M23.68 M24.47 M24.86 M26.02 M26.02 M — Diluted shares outstanding 21.31 M23.68 M24.47 M24.86 M6.33 M26.02 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —